ACA
Arcosa Inc
Arcosa Inc historical holders
total: 2
ValueAct Holdings Arcosa Inc transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 3
- Held since:
- 2018 Q4
- Held for:
- 4 quarters
- Latest activity:
- 2019 Q4
Jeffrey Ubben has been an institutional investor in Arcosa Inc (ACA) since 2018 Q4. According to 2026 Q1 report, Jeffrey Ubben doesn't hold any shares. The fund/company first acquired ACA in 2018 Q4, initially purchasing about 7.14M shares. Since the initial investment, ValueAct Holdings has made 4 more transactions in this position.
When did Jeffrey Ubben exit their ACA position?
Jeffrey Ubben no longer holds Arcosa Inc (ACA). They sold off their entire position in 2019 Q4, closing out an investment that began in 2018 Q4.
When did Jeffrey Ubben first invest in ACA?
Jeffrey Ubben first invested in Arcosa Inc (ACA) in 2018 Q4 at the reported quarter-end price of $27.69 per share, acquiring 7,135,963 shares in their initial purchase.
What is Jeffrey Ubben's average cost basis for ACA?
Based on historical transaction data, Jeffrey Ubben's estimated cost basis for Arcosa Inc (ACA) is approximately $27.69 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $27.69
- Weighted AVG sell price:
- $34.21
ACA transactions history by ValueAct Holdings
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$34.21
|
-100% (-1,577,265)
|
|||
|
2019 Q3
|
0.58%
|
$34.21
|
-62.81% (-2,663,698)
|
|||
|
2019 Q2
|
1.67%
|
$37.63
|
-26.13% (-1,500,000)
|
|||
|
2019 Q1
|
1.93%
|
$30.55
|
-19.55% (-1,395,000)
|
|||
|
2018 Q4
|
2.46%
|
$27.69
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.